Highly efficient nucleic acid encapsulation method for targeted gene therapy using antibody conjugation system.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Cancer Therapeutics

Background:

• Gene therapy offers targeted cancer treatment but requires effective nucleic acid delivery systems.
• Poly(lactic-co-glycolic acid) (PLGA) nanoparticles face challenges in nucleic acid encapsulation due to surface charge and size control.
• Prostate-specific membrane antigen (PSMA) is a target for prostate cancer therapy.

Purpose of the Study:

• To enhance nucleic acid encapsulation efficiency in PLGA nanoparticles.
• To develop a targeted gene delivery system for prostate cancer.
• To evaluate the antitumor efficacy of PSMA-targeted PLGA nanoparticles.

Main Methods:

• Utilized negatively charged microbeads and optimized formulation steps to improve nucleic acid encapsulation.
• Conjugated PSMA-617 ligand to PLGA nanoparticles for targeted delivery.
• Assessed antitumor effects in a prostate cancer model.

Main Results:

• Successfully improved nucleic acid encapsulation efficiency in PLGA nanoparticles.
• Demonstrated the potential of PSMA-targeted PLGA nanoparticles for prostate cancer therapy.
• The novel encapsulation technique is adaptable for various nucleic acids and targeting moieties.

Conclusions:

• The developed method offers a promising approach for efficient and targeted gene therapy delivery.
• This technique opens new avenues for precision therapeutics in cancer treatment.
• Further research can explore broader applications in oncology and other diseases.